Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia

Probiotics and Antimicrobial Proteins

Volumn 8, Issue 1, 2016, Pages 31-40

  Aroutcheva, Alla ^a   Auclair, Julie ^c   Frappier, Martin ^c   Millette, Mathieu ^c   Lolans, Karen ^b   de Montigny, Danielle ^b   Carrière, Serge ^c   Sokalski, Stephen ^d   Trick, William E ^a,b   Weinstein, Robert A ^a,b  

^a Jr Hospital of Cook County   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Bio K+ International Inc   (Canada)

^d ADVOCATE CHRIST MEDICAL CENTER   (United States)

Author keywords

Bacteremia; Lactobacilli; Molecular identification; Probiotic

Indexed keywords

AMIKACIN; ERTAPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PROBIOTIC AGENT; RNA 16S; BACTERIAL DNA; BACTERIAL RNA;

AGED; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEFIBRILLATOR; FEVER; FINGER DERMATOGLYPHICS; GENE AMPLIFICATION; GENOTYPE; HUMAN; ILEOSTOMY; ISCHEMIC COLITIS; KLEBSIELLA OXYTOCA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; LEFT VENTRICULAR ASSIST DEVICE; MALE; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; BACTERIUM IDENTIFICATION; CLASSIFICATION; CLOSTRIDIUM INFECTIONS; COMPLICATION; DNA FINGERPRINTING; GENETICS; HEART FAILURE; ISOLATION AND PURIFICATION; LACTOBACILLUS; MICROBIOLOGY; MOLECULAR TYPING; PEPTOCLOSTRIDIUM DIFFICILE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCEDURES; SPECIES DIFFERENCE;

AGED; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEART FAILURE; HUMANS; LACTOBACILLUS; MALE; MOLECULAR TYPING; PROBIOTICS; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SPECIES SPECIFICITY;

EID: 84964267066     PISSN: 18671306     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12602-016-9209-y     Document Type: Article

References (54)

1. Allen SJ (2015) The potential of probiotics to prevent Clostridium difficile infection. Infect Dis Clin North Am 29(1):135–144. doi:10.1016/j.idc.2014.11.002
2. Bartlett JG (2002) Clostridium difficile-associated enteric disease. Curr Infect Dis Rep 4(6):477–483
3. Aldeyab MA, Kearney MP, Scott MG et al (2012) An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 67(12):2988–2996. doi:10.1093/jac/dks330
4. Brown K, Valenta K, Fisman D et al (2015) Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 175(4):626–633. doi:10.1001/jamainternmed.2014.8273
5. Brace C, Gloor GB, Ropeleski M et al (2014) Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations. J Crohns Colitis 8(9):1133–1137. doi:10.1016/j.crohns.2014.01.020
6. Britton RA, Young VB (2014) Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146(6):1547–1553. doi:10.1053/j.gastro.2014.01.059
7. Kee VR (2012) Clostridium difficile infection in older adults: a review and update on its management. Am J Geriatr Pharmacother 10(1):14–24. doi:10.1016/j.amjopharm.2011.12.004
8. Lupse M, Flonta M, Cioara A et al (2013) Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center. J Gastrointestin Liver Dis 22(4):397–403
9. Kim JS, Ward KK, Shah NR et al (2013) Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics. Support Care Cancer 21(11):3103–3107. doi:10.1007/s00520-013-1888-2
10. Allen SJ, Wareham K, Wang D et al (2013) A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess 17(57):1–140. doi:10.3310/hta17570
11. Hickson M, D’Souza AL, Muthu N et al (2007) Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335(7610):80
12. Barker A, Duster M, Valentine S et al (2015) Probiotics for Clostridium difficile infection in adults (PICO): study protocol for a double-blind, randomized controlled trial. Contemp Clin Trials 44:26–32
13. Boonma P, Spinler JK, Venable SF et al (2014) Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells. BMC Microbiol 14:177-2180-14-177. doi:10.1186/1471-2180-14-177
14. Evans CT, Johnson S (2015) Prevention of Clostridium difficile infection with probiotics. Clin Infect Dis 60(Suppl 2):S122–S128. doi:10.1093/cid/civ138
15. Fitzpatrick LR (2013) Probiotics for the treatment of Clostridium difficile associated disease. World J Gastrointest Pathophysiol 4(3):47–52. doi:10.4291/wjgp.v4.i3.47
16. Goldenberg JZ, Ma SS, Saxton JD et al (2013) Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 5:CD006095. doi:10.1002/14651858.CD006095.pub3
17. Issa I, Moucari R (2014) Probiotics for antibiotic-associated diarrhea: do we have a verdict? World J Gastroenterol 20(47):17788–17795. doi:10.3748/wjg.v20.i47.17788
18. Chopra T, Goldstein EJ (2015) Clostridium difficile infection in long-term care facilities: a call to action for antimicrobial Stewardship. Clin Infect Dis 60(Suppl 2):S72–S76. doi:10.1093/cid/civ053
19. Johnston BC, Ma SS, Goldenberg JZ et al (2012) Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 157(12):878–888
20. Segarra-Newnham M (2007) Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii. Ann Pharmacother 41(7):1212–1221
21. McFarland LV (2015) Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections. Benef Microbes 6(2):189–194. doi:10.3920/BM2014.0034
22. Auclair J, Frappier M, Millette M (2015) Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K +): characterization, manufacture, mechanisms of action, and quality control of a specific probiotic combination for primary prevention of Clostridium difficile infection. Clin Infect Dis 60(Suppl 2):S135–S143. doi:10.1093/cid/civ179
23. Husni RN, Gordon SM, Washington JA et al (1997) Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 25(5):1048–1055
24. De Groote MA, Frank DN, Dowell E et al (2005) Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 24(3):278–280
25. Land MH, Rouster-Stevens K, Woods CR et al (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115(1):178–181
26. Haghighat L, Crum-Cianflone NF (2015) The potential risks of probiotics among HIV-infected persons: bacteraemia due to Lactobacillus acidophilus and review of the literature. Int J STD AIDS. doi:10.1177/0956462415590725
27. Ledoux D, Labombardi VJ, Karter D (2006) Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin’s disease. Int J STD AIDS 17(4):280–282. doi:10.1258/095646206776253507
28. Salvana EM, Frank M (2006) Lactobacillus endocarditis: case report and review of cases reported since 1992. J Infect 53(1):e5–e10
29. Simkins J, Kaltsas A, Currie BP (2013) Investigation of inpatient probiotic use at an academic medical center. Int J Infect Dis 17(5):e321–e324. doi:10.1016/j.ijid.2012.11.010
30. Rayes N, Hansen S, Seehofer D et al (2002) Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 18(7–8):609–615
31. Rayes N, Seehofer D, Hansen S et al (2002) Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74(1):123–127
32. Redman MG, Ward EJ, Phillips RS (2014) The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol 25(10):1919–1929. doi:10.1093/annonc/mdu106
33. Salminen MK, Rautelin H, Tynkkynen S et al (2004) Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 38(1):62–69
34. Tommasi C, Equitani F, Masala M et al (2008) Diagnostic difficulties of Lactobacillus casei bacteraemia in immunocompetent patients: a case report. J Med Case Rep 2:315-1947-2-315. doi:10.1186/1752-1947-2-315
35. Cannon JP, Lee TA, Bolanos JT et al (2005) Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24(1):31–40. doi:10.1007/s10096-004-1253-y
36. Gouriet F, Million M, Henri M et al (2012) Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur J Clin Microbiol Infect Dis 31(9):2469–2480. doi:10.1007/s10096-012-1599-5
37. Sullivan A, Nord CE (2006) Probiotic lactobacilli and bacteraemia in Stockholm. Scand J Infect Dis 38(5):327–331
38. Maziade PJ, Pereira P, Goldstein EJ (2015) A decade of experience in primary prevention of Clostridium difficile infection at a community hospital using the probiotic combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K +). Clin Infect Dis 60(Suppl 2):S144–S147. doi:10.1093/cid/civ178
39. Doron S, Snydman DR (2015) Risk and safety of probiotics. Clin Infect Dis 60(Suppl 2):S129–S134. doi:10.1093/cid/civ085
40. Versavovic J, Schneider GM, de Bruijn FP et al (1994) Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reaction. Methods Mol Biol (Clifton, NJ) 5(1):25–40
41. Labbe N, Jutea P, Parent S et al (2003) Bacterial diversity in a marine methanol-fed denitrification reactor at the Montreal Biodome, Canada. Microb Ecol 48:12–21
42. Klaenhammer TR, Kleeman EG (1981) Growth characteristics, bile sensitivity, and freeze damage in colonial variants of Lactobacillus acidophilus. Appl Environ Microbiol 41(6):1461–1467
43. Antony S, Dummer S, Stratton C (1998) Lactobacillus bacteremia and endocarditis. Clin Infect Dis 26(6):1483–1484
44. Horwitch CA, Furseth HA, Larson AM et al (1995) Lactobacillemia in three patients with AIDS. Clin Infect Dis 21(6):1460–1462
45. Saxelin M, Chuang NH, Chassy B et al (1996) Lactobacilli and bacteremia in southern Finland, 1989–1992. Clin Infect Dis 22(3):564–566
46. Schlegel L, Lemerle S, Geslin P (1998) Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur J Clin Microbiol Infect Dis 17(12):887–888
47. Song YL, Kato N, Matsumiya Y et al (1999) Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants. J Clin Microbiol 37(9):3062–3064
48. Presterl E, Kneifel W, Mayer HK et al (2001) Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion? Scand J Infect Dis 33(9):710–714
49. Sadowska-Krawczenko I, Paprzycka M, Korbal P et al (2014) Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction. Benef Microbes 5(4):397–402. doi:10.3920/BM2013.0074
50. Meini S, Laureano R, Fani L et al (2015) Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature. Infection. doi:10.1007/s15010-015-0798-2
51. Salminen MK, Tynkkynen S, Rautelin H et al (2002) Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 35(10):1155–1160
52. Ouwehand AC, Saxelin M, Salminen S (2004) Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin Infect Dis 39(12):1858–1860
53. Croucher NJ, Didelot X (2015) The application of genomics to tracing bacterial pathogen transmission. Curr Opin Microbiol 23:62–67. doi:10.1016/j.mib.2014.11.004
54. Olson ND, Lund SP, Colman RE et al (2015) Best practices for evaluating single nucleotide variant calling methods for microbial genomics. Front Genet 6:235. doi:10.3389/fgene.2015.00235